share_log

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $81

Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $81

Needham維持對Merit Medical Systems的買入,將目標價下調至81美元
Benzinga ·  2023/10/27 06:59

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $96 to $81.

Needham分析師Mike·馬特森維持納斯達克(Sequoia Capital:MMSI)的買入評級,並將目標價從96美元下調至81美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論